Pfizer Inc (NYSE:PFE)
| 44.26 Delayed Data As of Jan 26 |  +0.01 / +0.02%Today’s Change | 41.45 Today|||52-Week Range 56.32 | -13.62% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | 4.1B | -383.0M | 3.9B | 5.1B | |
| Depreciation | 1.6B | 1.6B | 1.5B | 1.5B | ||
| Total Other Cash Flow | -812.0M | 3.2B | -178.0M | -320.0M | ||
| Funds From Operations | 4.5B | 3.2B | 5.2B | 6.2B | ||
| Funds From/For Other Operating Expenses | -809.0M | -1.5B | 3.5B | 3.6B | ||
| Net Cash Flow - Operating Activities | 5.3B | 4.7B | 1.7B | 2.6B | ||
| Investing | Increase In Investments | -4.7B | -8.5B | -1.5B | -2.7B | |
| Decrease In Investments | 2.2B | 8.5B | 9.6B | 1.3B | ||
| Capital Expenditures | -547.0M | -685.0M | -460.0M | -479.0M | ||
| Other Investing - Sources | 111.0M | 38.0M | 68.0M | 112.0M | ||
| Net Cash Flow Investing | -2.9B | -764.0M | 7.6B | -1.9B | ||
| Financing | Short Term Borrowings | -4.2B | 924.0M | 875.0M | 3.4B | |
| Long Term Borrowings | 5.0B | 0.00 | 4.9B | 0.00 | ||
| Long Term Debt Reduction | 0.00 | -462.0M | -3.0B | -2.4B | ||
| Net Proceeds Stock Sale | 625.0M | 160.0M | 126.0M | 122.0M | ||
| Common Preferred Redeemed | -1.1B | -5.0B | -8.9B | 0.00 | ||
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -2.0B | -2.0B | -2.0B | -2.0B | ||
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | -278.0M | 36.0M | 496.0M | 45.0M | ||
| Net Cash Flow - Financing | -1.4B | -6.4B | -8.5B | -851.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -101.0M | 0.00 | 12.0M | -40.0M | |
| Net Change In Cash | 949.0M | -2.4B | 781.0M | -142.0M | ||